COGT

NASD Cogent Biosciences, Inc.
Oct 20, 2026 · 9:00 AM ET LAST TRADE Market Closed

$29.95 ↓ -0.06 (-0.20%) Trading Down from the previous close of $30.01

YTD change
-15.68%
vs 20-day SMA
-2.36%
vs 200-day SMA
-16.53%

Price ranges

Previous day
$29.51 $30.23
open $29.66 close $30.01
+$0.35 (+1.18%)
Today
$0.00 $0.00
$29.95
Past week
$27.74 $30.23
from $29.78 now $29.95
+$0.17 (+0.57%)
Past month
$27.74 $32.85
from $32.00 now $29.95
-$2.05 (-6.41%)
This year
$27.74 $43.39
from $35.52 now $29.95
-$5.57 (-15.68%)

Price & Performance

-6.99 (-18.89%) / 6M

$26.91$32.61$38.32$44.02Apr 20Jul 21Oct 19

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 31.5% away from all-time highs of $43.73
  • COGT is down 16% since the beginning of the year
  • COGT is up 85% over the past 12 months
  • COGT is down 6% over the past 1 month
  • 10% of all COGT investors are betting against COGT

COGT reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is +85.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.52
Earnings momentum +6.4% Quarterly EPS growth
Quarterly change +6.4%

Valuation

P/E ratio N/A
Enterprise value $4.6B
Beta 0.88

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$792.3M
Debt$244.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $5.6B

Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation and other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $424.94 -1.75%
MRNA Moderna, Inc. $226.89 +4.07%
RVMD Revolution Medicines, Inc. $182.15 +2.35%
ROIV Roivant Sciences Ltd. $34.70 +3.49%
BNTX BioNTech SE Sponsored ADR $89.21 +1.71%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.